nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—Benzphetamine—POR—urinary bladder cancer	0.0374	0.645	CrCbGaD
Levomethadyl Acetate—Tamoxifen—ESR2—urinary bladder cancer	0.0127	0.22	CrCbGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00915	0.00971	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00892	0.00946	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTO2—urinary bladder cancer	0.00881	0.00935	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—NAT1—urinary bladder cancer	0.00881	0.00935	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00869	0.00922	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00835	0.00887	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.00835	0.00886	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.00831	0.00882	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00829	0.0088	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00824	0.00874	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—UGT2B7—urinary bladder cancer	0.00805	0.00855	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00794	0.00843	CbGpPWpGaD
Levomethadyl Acetate—Tamoxifen—ESR1—urinary bladder cancer	0.00785	0.135	CrCbGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP4B1—urinary bladder cancer	0.00725	0.0077	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00715	0.00759	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTZ1—urinary bladder cancer	0.00672	0.00713	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00662	0.00703	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.00637	0.00676	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.00637	0.00676	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.00636	0.00675	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00628	0.00667	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.00582	0.00618	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00574	0.0061	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00566	0.00601	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00559	0.00593	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—NAT2—urinary bladder cancer	0.00556	0.0059	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—FSH signaling pathway—SRC—urinary bladder cancer	0.0055	0.00584	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00548	0.00582	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.00524	0.00557	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00517	0.00549	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00487	0.00517	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—NAT2—urinary bladder cancer	0.00483	0.00512	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00476	0.00505	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00459	0.00487	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00457	0.00485	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00444	0.00472	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.0044	0.00468	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00439	0.00466	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00431	0.00457	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—FAS—urinary bladder cancer	0.00417	0.00443	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—HPGDS—urinary bladder cancer	0.00386	0.0041	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTT1—urinary bladder cancer	0.00374	0.00397	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.0035	0.00371	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.00349	0.0037	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00344	0.00365	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00321	0.0034	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00312	0.00331	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00308	0.00327	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.003	0.00318	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00299	0.00317	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00296	0.00314	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00296	0.00314	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00295	0.00313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00292	0.0031	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.00279	0.00296	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.00274	0.00291	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.00271	0.00287	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00271	0.00287	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.0027	0.00287	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00267	0.00283	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTP1—urinary bladder cancer	0.00259	0.00275	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00256	0.00272	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00244	0.00259	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00243	0.00258	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00241	0.00256	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.0024	0.00255	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.0024	0.00255	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00239	0.00254	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.00238	0.00253	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00235	0.0025	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.00224	0.00238	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.0021	0.00223	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.00209	0.00222	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.00208	0.00221	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.00205	0.00217	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.00187	0.00199	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00185	0.00196	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.00183	0.00194	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.00173	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.00173	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.00172	0.00183	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00171	0.00181	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.0017	0.0018	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.00168	0.00179	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00162	0.00172	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.0016	0.0017	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.00159	0.00169	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.00159	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.00155	0.00165	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.00154	0.00163	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.00151	0.0016	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.00151	0.0016	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.0015	0.00159	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—urinary bladder cancer	0.00149	0.00158	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.00143	0.00152	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.00143	0.00152	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.0014	0.00149	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.00138	0.00146	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.00135	0.00143	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.00131	0.0014	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.0013	0.00138	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—HRAS—urinary bladder cancer	0.00129	0.00137	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.00126	0.00133	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.00124	0.00132	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.00124	0.00132	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.00122	0.00129	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.00118	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—HRAS—urinary bladder cancer	0.00118	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.00117	0.00124	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.00115	0.00122	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.00115	0.00122	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.00114	0.00121	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.00109	0.00116	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.00109	0.00116	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HDAC4—urinary bladder cancer	0.00106	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00105	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.00105	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.00102	0.00108	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00101	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000996	0.00106	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.00095	0.00101	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000938	0.000996	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000912	0.000969	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000897	0.000952	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	0.000887	0.000942	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000872	0.000925	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00086	0.000913	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.000847	0.000899	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000825	0.000876	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000825	0.000876	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.00082	0.000871	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000801	0.00085	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00079	0.000839	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.00076	0.000806	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.00076	0.000806	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000755	0.000802	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000737	0.000782	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000726	0.00077	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000715	0.000759	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—RRM2—urinary bladder cancer	0.000712	0.000756	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	0.00066	0.0007	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ENO2—urinary bladder cancer	0.00066	0.0007	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.00066	0.0007	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	0.00064	0.000679	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000612	0.00065	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	0.000608	0.000645	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NAT2—urinary bladder cancer	0.000597	0.000633	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000594	0.000631	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	0.000572	0.000607	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	0.000544	0.000578	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000534	0.000567	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NQO1—urinary bladder cancer	0.000532	0.000565	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000518	0.00055	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—RRM2—urinary bladder cancer	0.000515	0.000547	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000511	0.000542	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	0.000506	0.000537	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NAT1—urinary bladder cancer	0.000506	0.000537	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000494	0.000525	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ENO2—urinary bladder cancer	0.000477	0.000506	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	0.000477	0.000506	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000475	0.000504	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000469	0.000498	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000469	0.000498	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	0.000463	0.000491	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	0.000463	0.000491	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	0.00046	0.000488	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000449	0.000477	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	0.000444	0.000471	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000441	0.000468	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	0.000441	0.000468	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	0.000418	0.000444	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	0.000417	0.000442	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.000415	0.00044	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TYMS—urinary bladder cancer	0.000412	0.000438	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	0.000408	0.000433	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	0.000408	0.000433	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000404	0.000429	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000396	0.000421	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	0.000394	0.000418	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GPX1—urinary bladder cancer	0.00039	0.000414	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	0.000386	0.00041	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NQO1—urinary bladder cancer	0.000384	0.000408	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	0.000384	0.000407	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	0.000383	0.000407	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000367	0.000389	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	0.00036	0.000382	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	0.00035	0.000372	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	0.000349	0.000371	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPARG—urinary bladder cancer	0.000336	0.000357	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	0.000323	0.000343	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	0.000321	0.00034	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	0.00032	0.00034	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	0.000311	0.00033	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TYMP—urinary bladder cancer	0.000307	0.000326	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TYMS—urinary bladder cancer	0.000298	0.000316	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	0.000295	0.000313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	0.000295	0.000313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPARG—urinary bladder cancer	0.000292	0.00031	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GPX1—urinary bladder cancer	0.000282	0.0003	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	0.000281	0.000298	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NAT2—urinary bladder cancer	0.000277	0.000294	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	0.000277	0.000294	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	0.000273	0.00029	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	0.000269	0.000286	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	0.000268	0.000285	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	0.000265	0.000281	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	0.00026	0.000276	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	0.000253	0.000269	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	0.000247	0.000262	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—RRM2—urinary bladder cancer	0.000239	0.000254	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTEN—urinary bladder cancer	0.000231	0.000245	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	0.00023	0.000244	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	0.000228	0.000243	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	0.000222	0.000235	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ENO2—urinary bladder cancer	0.000222	0.000235	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—EP300—urinary bladder cancer	0.00022	0.000234	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	0.000217	0.00023	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	0.000215	0.000229	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	0.000215	0.000228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPARG—urinary bladder cancer	0.000211	0.000224	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	0.000207	0.00022	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	0.000203	0.000215	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	0.000202	0.000214	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTEN—urinary bladder cancer	0.0002	0.000213	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	0.000196	0.000208	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000195	0.000207	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	0.000195	0.000207	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—EP300—urinary bladder cancer	0.000191	0.000203	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	0.000186	0.000197	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	0.000181	0.000192	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NQO1—urinary bladder cancer	0.000179	0.00019	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	0.000166	0.000176	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	0.000162	0.000172	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	0.000158	0.000168	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	0.00015	0.000159	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	0.000149	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTEN—urinary bladder cancer	0.000145	0.000154	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TYMS—urinary bladder cancer	0.000139	0.000147	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—EP300—urinary bladder cancer	0.000138	0.000147	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	0.000137	0.000145	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	0.000137	0.000145	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	0.000133	0.000141	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GPX1—urinary bladder cancer	0.000131	0.000139	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	0.000129	0.000137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	0.000127	0.000135	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	0.000121	0.000129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.82e-05	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.43e-05	0.0001	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.72e-05	8.2e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.73e-05	7.15e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.42e-05	6.82e-05	CbGpPWpGaD
